2877 logo

China Shineway Pharmaceutical Group SZSC:2877 Stock Report

Last Price

HK$8.75

Market Cap

HK$6.6b

7D

4.3%

1Y

-8.6%

Updated

11 Mar, 2025

Data

Company Financials +

China Shineway Pharmaceutical Group Limited

SZSC:2877 Stock Report

Market Cap: HK$6.6b

2877 Stock Overview

An investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong. More details

2877 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance5/6
Financial Health5/6
Dividends4/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

China Shineway Pharmaceutical Group Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for China Shineway Pharmaceutical Group
Historical stock prices
Current Share PriceHK$8.75
52 Week HighHK$10.76
52 Week LowHK$7.58
Beta0.80
1 Month Change3.18%
3 Month Change-17.45%
1 Year Change-8.57%
3 Year Change47.06%
5 Year Change59.09%
Change since IPO8.43%

Recent News & Updates

Recent updates

Shareholder Returns

2877HK PharmaceuticalsHK Market
7D4.3%2.8%3.3%
1Y-8.6%3.8%27.9%

Return vs Industry: 2877 underperformed the Hong Kong Pharmaceuticals industry which returned 3.8% over the past year.

Return vs Market: 2877 underperformed the Hong Kong Market which returned 27.9% over the past year.

Price Volatility

Is 2877's price volatile compared to industry and market?
2877 volatility
2877 Average Weekly Movement5.1%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement6.8%
10% most volatile stocks in HK Market14.3%
10% least volatile stocks in HK Market3.2%

Stable Share Price: 2877 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 2877's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20023,232n/awww.shineway.com

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products.

China Shineway Pharmaceutical Group Limited Fundamentals Summary

How do China Shineway Pharmaceutical Group's earnings and revenue compare to its market cap?
2877 fundamental statistics
Market capHK$6.61b
Earnings (TTM)HK$1.19b
Revenue (TTM)HK$4.52b

5.6x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2877 income statement (TTM)
RevenueCN¥4.20b
Cost of RevenueCN¥1.04b
Gross ProfitCN¥3.16b
Other ExpensesCN¥2.06b
EarningsCN¥1.10b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.46
Gross Margin75.21%
Net Profit Margin26.27%
Debt/Equity Ratio4.5%

How did 2877 perform over the long term?

See historical performance and comparison

Dividends

6.4%

Current Dividend Yield

37%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/11 21:41
End of Day Share Price 2025/03/11 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

China Shineway Pharmaceutical Group Limited is covered by 26 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Derrick SunBNP Paribas Securities (Asia)
Ying ShaoBofA Global Research
Shun Kei LawCCB International Securities Limited